Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

2NTE

Crystal Structure of the BARD1 BRCT Domains

Summary for 2NTE
Entry DOI10.2210/pdb2nte/pdb
DescriptorBRCA1-associated RING domain protein 1, SULFATE ION, CHLORIDE ION, ... (5 entities in total)
Functional Keywordsbrct, ring finger, brca1, zinc-binding protein, ubiquitin ligase, antitumor protein
Biological sourceHomo sapiens (human)
Cellular locationNucleus: Q99728
Total number of polymer chains2
Total formula weight48814.64
Authors
Birrane, G.,Varma, A.K.,Soni, A.,Ladias, J.A.A. (deposition date: 2006-11-07, release date: 2007-06-12, Last modification date: 2024-12-25)
Primary citationBirrane, G.,Varma, A.K.,Soni, A.,Ladias, J.A.
Crystal structure of the BARD1 BRCT domains.
Biochemistry, 46:7706-7712, 2007
Cited by
PubMed Abstract: The interaction of the breast tumor suppressor BRCA1 with the protein BARD1 results in the formation of a heterodimeric complex that has ubiquitin ligase activity and plays central roles in cell cycle checkpoint control and DNA repair. Both BRCA1 and BARD1 possess a pair of tandem BRCT domains that interact in a phosphorylation-dependent manner with target proteins. We determined the crystal structure of the human BARD1 BRCT repeats (residues 568-777) at 1.9 A resolution. The composition and structure of the BARD1 phosphoserine-binding pocket P1 are strikingly similar to those of the BRCA1 and MDC1 BRCT domains, suggesting a similar mode of interaction with the phosphate group of the ligand. By contrast, the BARD1 BRCT selectivity pocket P2 exhibits distinct structural features, including two prominent histidine residues, His685 and His686, which may be important for ligand binding. The protonation state of these histidines has a marked effect on the calculated electrostatic potential in the vicinity of P2, raising the possibility that ligand recognition may be regulated by changes in pH. Importantly, the BARD1 BRCT structure provides insights into the mechanisms by which the cancer-associated missense mutations C645R, V695L, and S761N may adversely affect the structure and function of BARD1.
PubMed: 17550235
DOI: 10.1021/bi700323t
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (1.9 Å)
Structure validation

246905

PDB entries from 2025-12-31

PDB statisticsPDBj update infoContact PDBjnumon